ARTICLE | Company News
CyDex Inc., TargeGen deal
July 5, 2004 7:00 AM UTC
TargeGen licensed rights to use CyDex's Captisol drug delivery technology to formulate TG 100-115, a kinase inhibitor in preclinical development to treat myocardial infarction. Captisol is a donut-sha...